# CASPOFUNGIN ACETATE
> **ANDA211263** · Abbreviated New Drug Application (Generic) · Sponsor: AREVA PHARMS · Approved 2021-10-01
## Drug
- **FDA Application Number:** ANDA211263
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CASPOFUNGIN ACETATE
- **Generic name:** Caspofungin Acetate
- **Active ingredients:** CASPOFUNGIN ACETATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AREVA PHARMS
- **First approval:** 2021-10-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211263)
---
*MORVS · CC0 1.0*